Lonza News 2026-01-29 Narrow-Moat Lonza's Long-Term Outlook Driven by Strong Outsourced Drug Manufacturing Demand - Morningstar
FierceBiotech 2026-01-28 Reducing animal testing 'an evolution and not a revolution' for life sci R&D, Charles River's incoming CEO says
FierceBiotech 2026-01-28 New compound shrinks brain tumors in mice, sparking hope for a glioblastoma pill
FierceBiotech 2026-01-28 Halozyme catches M&A wave to snap up Surf Bio in delivery tech deal worth up to $400M
BioPharma Dive 2026-01-28 Lilly bets on Seamless, delving further into genetic medicine for hearing loss
Lonza News 2026-01-28 Lonza still intends to sell its capsules and health ingredients business - Endpoints News